Skip to content

Article: Timing of NAD+ Precursors Determines Neuroprotection After Stroke: Preclinical Findings

Timing of NAD+ Precursors Determines Neuroprotection After Stroke: Preclinical Findings


Synopsis

Researchers studying nicotinamide riboside (NR) and nicotinamide (NAM)—both vitamin B3-based NAD+ boosters—found that the timing of supplementation plays a critical role in brain recovery after a stroke. In mice with blocked brain arteries, a single dose of NR or NAM given after the stroke improved brain tissue recovery and neurological function within 72 hours. However, daily doses given before the stroke had the opposite effect, making brain damage worse. The study suggests that while a single post-stroke treatment increases protective molecules like AMPK, PGC-1α, SIRT1, and ATP, repeated pre-treatment disrupts this balance. These results show that NAD+ precursors can be neuroprotective when used after a stroke, but taking them preventively may increase vulnerability to brain injury.

Journal

Journal of Cerebral Blood Flow & Metabolism

Read more

Cancer

Beyond Pellagra—NAD+ Deficiency in Aging and Disease: Review

SynopsisInterest in NAD+ has surged because low NAD+ levels are linked to many health problems, including metabolic diseases, neurodegeneration, reproductive disorders, cancer, and aging. Researche...

Read more
Healthy Aging & Longevity

Nicotinamide Riboside Boosts NAD+ to Improve Telomere Stability: Preclinical Findings

SynopsisTelomere biology disorders (TBDs), such as dyskeratosis congenita (DC), are characterized by critically short telomeres and often lead to bone marrow failure. A key metabolic molecule, NAD+...

Read more